Gian Carlo Avanzi

5.0k total citations · 1 hit paper
92 papers, 2.8k citations indexed

About

Gian Carlo Avanzi is a scholar working on Immunology, Surgery and Neurology. According to data from OpenAlex, Gian Carlo Avanzi has authored 92 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Immunology, 17 papers in Surgery and 14 papers in Neurology. Recurrent topics in Gian Carlo Avanzi's work include Phagocytosis and Immune Regulation (20 papers), COVID-19 Clinical Research Studies (10 papers) and Erythrocyte Function and Pathophysiology (8 papers). Gian Carlo Avanzi is often cited by papers focused on Phagocytosis and Immune Regulation (20 papers), COVID-19 Clinical Research Studies (10 papers) and Erythrocyte Function and Pathophysiology (8 papers). Gian Carlo Avanzi collaborates with scholars based in Italy, United States and France. Gian Carlo Avanzi's co-authors include Luigi Mario Castello, C. Schneider, Guidalberto Manfioletti, Claudio Brancolini, Pier Paolo Sainaghi, Luigi Pegoraro, Federica Alciato, Maria Felice Brizzi, Francesco Gavelli and Daniele Sola and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Gian Carlo Avanzi

87 papers receiving 2.7k citations

Hit Papers

The protein encoded by a growth arrest-specific gene (gas... 1993 2026 2004 2015 1993 100 200 300 400 500

Peers

Gian Carlo Avanzi
Gian Carlo Avanzi
Citations per year, relative to Gian Carlo Avanzi Gian Carlo Avanzi (= 1×) peers Elisa Gremese

Countries citing papers authored by Gian Carlo Avanzi

Since Specialization
Citations

This map shows the geographic impact of Gian Carlo Avanzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gian Carlo Avanzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gian Carlo Avanzi more than expected).

Fields of papers citing papers by Gian Carlo Avanzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gian Carlo Avanzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gian Carlo Avanzi. The network helps show where Gian Carlo Avanzi may publish in the future.

Co-authorship network of co-authors of Gian Carlo Avanzi

This figure shows the co-authorship network connecting the top 25 collaborators of Gian Carlo Avanzi. A scholar is included among the top collaborators of Gian Carlo Avanzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gian Carlo Avanzi. Gian Carlo Avanzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rizzi, Manuela, Stelvio Tonello, Rosalba Minisini, et al.. (2023). COVID-19 Biomarkers at the Crossroad between Patient Stratification and Targeted Therapy: The Role of Validated and Proposed Parameters. International Journal of Molecular Sciences. 24(8). 7099–7099. 11 indexed citations
2.
Gavelli, Francesco, Filippo Patrucco, Nello De Vita, Paolo Solidoro, & Gian Carlo Avanzi. (2023). Central venous pressure in critically ill patients: do we still need it?. Panminerva Medica. 66(1). 1–3. 1 indexed citations
3.
Rizzi, Manuela, Martina Costanzo, Stelvio Tonello, et al.. (2022). Prognostic Markers in Hospitalized COVID-19 Patients: The Role of IP-10 and C-Reactive Protein. Disease Markers. 2022. 1–14. 13 indexed citations
4.
Gavelli, Francesco, Livia Salmi, Filippo Mearelli, et al.. (2022). Are Baseline Levels of Gas6 and Soluble Mer Predictors of Mortality and Organ Damage in Patients with Sepsis? The Need-Speed Trial Database. Biomedicines. 10(2). 198–198. 2 indexed citations
5.
Tonello, Stelvio, Manuela Rizzi, Erica Matino, et al.. (2022). Baseline Plasma Gas6 Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients. Disease Markers. 2022. 1–7. 12 indexed citations
6.
Salmi, Livia, Francesco Gavelli, Filippo Patrucco, et al.. (2021). Growth Arrest-Specific Gene 6 Administration Ameliorates Sepsis-Induced Organ Damage in Mice and Reduces ROS Formation In Vitro. Cells. 10(3). 602–602. 8 indexed citations
7.
Gavelli, Francesco, Luigi Mario Castello, & Gian Carlo Avanzi. (2021). Management of sepsis and septic shock in the emergency department. Internal and Emergency Medicine. 16(6). 1649–1661. 84 indexed citations
8.
Gavelli, Francesco, Luigi Mario Castello, Mattia Bellan, et al.. (2021). Clinical stability and in-hospital mortality prediction in COVID-19 patients presenting to the Emergency Department. Minerva Medica. 112(1). 118–123. 11 indexed citations
9.
Castello, Luigi Mario, Francesco Gavelli, Livia Salmi, et al.. (2020). Hypernatremia and moderate-to-severe hyponatremia are independent predictors of mortality in septic patients at emergency department presentation: A sub-group analysis of the need-speed trial. European Journal of Internal Medicine. 83. 21–27. 21 indexed citations
10.
Gavelli, Francesco, Jean–Louis Teboul, Danila Azzolina, et al.. (2020). Transpulmonary thermodilution detects rapid and reversible increases in lung water induced by positive end-expiratory pressure in acute respiratory distress syndrome. Annals of Intensive Care. 10(1). 28–28. 18 indexed citations
11.
Guglielmetti, Gabriele, Marco Quaglia, Pier Paolo Sainaghi, et al.. (2020). “War to the knife” against thromboinflammation to protect endothelial function of COVID-19 patients. Critical Care. 24(1). 36 indexed citations
12.
Castello, Luigi Mario, Livia Salmi, Vincenzo Cantaluppi, et al.. (2019). The Role of Osteopontin as a Diagnostic and Prognostic Biomarker in Sepsis and Septic Shock. Cells. 8(2). 174–174. 32 indexed citations
13.
Castello, Luigi Mario, et al.. (2017). Acute decompensated heart failure in the emergency department. Medicine. 96(27). e7401–e7401. 8 indexed citations
14.
Molin, Alberto Dal, et al.. (2015). PULMONARY EMBOLISM RISK ASSESSMENT: APPLICATION OF THE REVISED GENEVA SCORE IN AN EMERGENCY DEPARTMENT. 8(1). 49–58.
15.
Somma, Salvatore Di, L. Magrini, Francesco Travaglino, et al.. (2013). Opinion paper on innovative approach of biomarkers for infectious diseases and sepsis management in the emergency department. Clinical Chemistry and Laboratory Medicine (CCLM). 51(6). 1167–1175. 41 indexed citations
16.
Alciato, Federica, et al.. (2008). Development and Validation of an ELISA Method for Detection of Growth Arrest Specific 6 (GAS6) Protein in Human Plasma. Journal of Immunoassay and Immunochemistry. 29(2). 167–180. 32 indexed citations
17.
Sainaghi, Pier Paolo, Federica Alciato, Luigi Mario Castello, et al.. (2008). Gas6 evaluation in patients with acute dyspnea due to suspected pulmonary embolism. Respiratory Medicine. 103(4). 589–594. 19 indexed citations
18.
Brizzi, Maria Felice, Giovanni Maria Garbarino, Giovanni Luca Pagliardi, et al.. (1993). Interleukin 3 stimulates proliferation and triggers endothelial-leukocyte adhesion molecule 1 gene activation of human endothelial cells.. Journal of Clinical Investigation. 91(6). 2887–2892. 82 indexed citations
19.
Ghigo, Dario, Maria Felice Brizzi, Gian Carlo Avanzi, et al.. (1990). Evidence for a role of the Na+/H+ exchanger in the colony‐stimulating‐factor‐induced ornithine decarboxylase activity and proliferation of the human cell line M‐07e. Journal of Cellular Physiology. 145(1). 147–154. 9 indexed citations
20.
Avanzi, Gian Carlo, et al.. (1978). HLA-matched platelets from unrelated donors in the supportive therapy of patients undergoing intensive haematologic treatment.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 63(5). 575–85. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026